Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

biogen netherlands b.v.  - fampridine - roztrúsená skleróza - Ďalšie lieky na nervový systém - fampyra je indikovaná na zlepšenie chôdze u dospelých pacientov s roztrúsenou sklerózou s postihnutím v chôdzi (expanded disability status scale 4-7).

Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ozanimod hydrochlorid - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresíva - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

accord healthcare s.l.u. - fampridine - roztrúsená skleróza - Ďalšie lieky na nervový systém - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Σλοβακία - Σλοβακικά - ŠÚKL (Štátny ústav pre kontrolu liečiv)

teva pharmaceuticals slovakia s.r.o., slovensko - fampridín - 87 - varia i

Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - spesolimab - svrab - imunosupresíva - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.